(The Center Square) – Litigation involving “transition-related medical procedures and medications” in the State Health Plan of North Carolina has been sent back to the 4th U.S. Circuit Court of Appeals by the U.S. Supreme Court.
Monday’s announcement in Folwell v. Kadel said “further consideration in light of United States v. Skrmetti” was needed. In that case, the nation’s highest court sided with Tennessee law that bans puberty blockers and hormone therapy for teens.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.